TCI Wealth Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-40
Closed -$295 1086
2023
Q1
$295 Hold
40
﹤0.01% 2289
2022
Q4
$324 Hold
40
﹤0.01% 2272
2022
Q3
$1K Hold
40
﹤0.01% 2095
2022
Q2
$1K Buy
40
+20
+100% +$331 ﹤0.01% 2145
2022
Q1
$0 Buy
+20
New +$358 ﹤0.01% 2313
2021
Q4
Sell
-26
Closed -$2K 2384
2021
Q3
$2K Hold
26
﹤0.01% 2129
2021
Q2
$2K Hold
26
﹤0.01% 2017
2021
Q1
$3K Buy
+26
New +$3.14K ﹤0.01% 1529

Other funds holding HOOK

TCI Wealth Advisors's HOOK Position: Q2 2023 in Review

TCI Wealth Advisors sold out of HOOKIPA Pharma (HOOK) in Q2 2023, closing a stake of 40 shares — an estimated $295 sold.

TCI Wealth Advisors first reported a position in HOOK in Q1 2021 and held it in 8 quarters. The position peaked at $3K in Q1 2021. 53 funds tracked by Wall St. Rank hold HOOK as of Q2 2023.

  • TCI Wealth Advisors reported no remaining HOOKIPA Pharma position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 40 HOOKIPA Pharma shares in Q2 2023, an estimated $295.
  • TCI Wealth Advisors first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's HOOKIPA Pharma position peaked at $3K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.